Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience

Immunoglobulin (Ig) D multiple myeloma (MM) accounts for 2% of all MM cases and has been reported to be associated with poor prognosis compared with other MM subtypes. The aim of the present study was to compare the effects of high-dose melphalan treatment and autologous stem cell transplantation (A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chong, Yong Pil, Kim, Shin, Ko, Ok Bae, Koo, Ja Eun, Lee, Danbi, Park, Sang Hyoung, Park, Soo Jung, Lee, Daeho, Kim, Sang We, Suh, Cheolwon
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Medical Sciences 2008
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2580008/
https://ncbi.nlm.nih.gov/pubmed/18955788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2008.23.5.819
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados